Skip to content
VuFind
Advanced
  • Release and swelling studies o...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
QR Code

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)

Bibliographic Details
Main Authors: Mooranian, A., Negrulj, R., Al-Sallami, H., Fang, Z., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Arfuso, Frank, Al-Salami, S.
Format: Journal Article
Published: Informa Healthcare 2015
Online Access:http://hdl.handle.net/20.500.11937/58456
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/58456

Similar Items

  • Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
    by: Mooranian, Armin, et al.
    Published: (2015)
  • Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
    by: Negrulj, R., et al.
    Published: (2015)
  • Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
    by: Mooranian, A., et al.
    Published: (2015)
  • Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
    by: Mooranian, Armin, et al.
    Published: (2014)
  • Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
    by: Mooranian, Armin, et al.
    Published: (2014)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips